AIDS-related cancer care and prevention in people living with HIV
Official title: Consortium for Advancing Management and Prevention of Cancer in People with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-11416556 · Data updated 2026-11-12
This grant funds clinical trials to test new cancer treatments and prevention strategies for people living with HIV, aiming to reduce cancer cases and improve survival.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 29, 2006 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $21,522,826 |
| NIH project number | 5UM1CA121947-20 |
| Project ID | NIH-11416556 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with HIV who are at risk for or diagnosed with AIDS-related cancers.
✕Less likely to help
Patients without HIV or without an AIDS-related cancer may not directly benefit from these trials.
What this research studies
The AIDS Malignancy Consortium coordinates multiple sites to conduct trials and studies focused on cancers that affect people with HIV. It involves collaboration with clinicians, researchers, and patient communities to test interventions and understand how cancer develops in this population. The program has a long track record of thousands of participants and has influenced guidelines in diverse settings, including resource-limited regions. Researchers work across the U.S. and international sites to advance care and outcomes for patients with HIV-associated cancers.
Why it matters
Potential benefit: If successful, patients with HIV could experience better cancer prevention, earlier detection, and more effective, tailored treatments.
How similar studies have gone: Prior AMC trials have shaped practice guidelines and improved outcomes for HIV-associated cancers.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.